openPR Logo
Press release

Global Non-infectious Diarrhea Treatment Market to Showcase Vigorous Demand during the Period until 2028|| Top industry players- Abbott Laboratories, Aidarex Pharmaceuticals LLC, Atlantic Biologicals Corps, Major Pharmaceuticals, Proficient Rx LP and more

10-12-2018 12:18 PM CET | Health & Medicine

Press release from: Fact.MR

Global Non-infectious Diarrhea Treatment Market to Showcase

Anti-Diarrheal medications have been gaining significant traction in non-infectious diarrhea treatment market coupled with oral rehydration solution for preventing or treating loss of fluid. Although oral rehydration solution is expected to burgeon growth of Non-infectious Diarrhea Treatment Market, zinc supplementation helps in reducing severity and duration of non-infectious diarrhea treatment. Zinc supplements for non-infectious diarrhea treatment is anticipated to gain significant traction amongst caregivers and children on a larger basis. Furthermore, demand for zinc supplements in non-infectious diarrhea treatment is attracting consumer attention as it offers vital micronutrients that are essential for intestinal transport of electrolytes and water, immune function and protein synthesis.

Request a sample of the Non-infectious Diarrhea Treatment Market report: https://www.factmr.com/connectus/sample?flag=S&rep_id=961

Zinc supplements are not only beneficial for non-infectious diarrhea treatment but also supports in normal development and growth of children. With advantages of zinc supplements in non-infectious diarrhea treatment, lies barriers restraining the non-infectious diarrhea treatment market on a larger basis. Dearth of acceptance of zinc supplements in non-infectious diarrhea treatment by healthcare workers and physicians is likely to restrain the growth of non-infectious diarrhea treatment market. Key players and manufacturers in non-infectious diarrhea treatment market are expected to make heavy investments in R&D for establishing optimal dosage with zinc supplements, especially for children.

Non-infectious diarrhea often lasts for a few days and results in dehydration due to the loss of fluid content in the body. It is a condition that entails at least three or more liquid or loose bowel movements within a day. It often lasts for a few days and results in dehydration due to loss in fluid content of the body. Various non-infectious causes of non-infectious diarrhea include inflammatory bowel disease, lactose intolerance, non-celiac gluten sensitivity, hyperthyroidism, irritable bowel syndrome, bile acid diarrhea and a number of medications. In most cases, stool cultures need not be studied to identify the cause. Globally, approximately 1.7- 5 billion cases of diarrhea occur every year. Non-infectious diarrhea is most common in developing countries where children get diarrhea, on an average, three times a year. Diarrhea accounted for approximately 1.26 million deaths in 2013. It is one of the most common causes of death in children younger than five years in age. Frequent episodes of diarrhea can also cause malnutrition. Other long term problems of non-infectious diarrhea include poor-intellectual development and stunted growth. Non-infectious diarrhea can be improved by sanitation and clean drinking water. Zinc tablets and Oral Rehydration Solution (ORS) - a solution with modest amounts of salts and sugar, are some of the most preferred treatments for non-infectious diarrhea. 

Non-infectious Diarrhea Treatment Market: Drivers

The growing prevalence and recurrence of non-infectious diarrhea is expected to be a major factor driving factor for the growth of the non-infectious diarrhea treatment market over the forecast period. According to the Centers for Disease Control and Prevention (CDC), diarrhea kills more children than malaria, measles and AIDS combined. Changes is lifestyle and eating habits are contributing to the growing prevalence of non-infectious diarrhea. The launch and addition of new products is another factor contributing to the growth of the global non-infectious diarrhea treatment market.

To get complete report about Non-infectious Diarrhea Treatment Market, visit this link: https://www.factmr.com/report/961/non-infectious-diarrhea-treatment-market

Non-infectious Diarrhea Treatment Market: Segmentation

Tentatively, the global non-infectious diarrhea treatment market can be segmented on the basis of treatment type, distribution channel, and geography.

Based on treatment type, the global non-infectious diarrhea treatment market can be segmented as:

Anti-Diarrheal medications
Bismuth Subsalicylate
Diphenoxylate
Atropine
Others
Nutrition
Zinc Supplements
Vitamin A supplements
Fluids
Oral Rehydration Solution
Electrolytes
Others
Based on distribution channel, the global non-infectious diarrhea treatment market can be segmented as:

Hospital Pharmacy
Retail Pharmacies
Drug Stores
Online Pharmacy
Others
Based on geography, the global non-infectious diarrhea treatment market can be segment as:

North America
Latin America
Europe
Asia Pacific
Japan
Middle-East & Africa
Non-Infectious Diarrhea Treatment Market: Market Participants

The global market for diverticular disease therapeutics is highly fragmented. Examples of some of the key players operating in the global non-infectious diarrhea treatment market are Abbott Laboratories, Aidarex Pharmaceuticals LLC, Atlantic Biologicals Corps, Major Pharmaceuticals, Proficient Rx LP, Chattem Inc., V.Excel International, ANI Pharmaceuticals Inc. and others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Regional analysis includes

North America (U.S., Canada)
Latin America (Mexico, Brazil)
Western Europe (Germany, Italy, U.K., Spain, France, Nordic countries, BENELUX)
Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
Asia Pacific Excluding Japan (China, India, Australia & New Zealand)
Japan
Middle East and Africa (GCC, S. Africa, Rest Of MEA)
Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint
For any query, Connect with Industry experts at: https://www.factmr.com/connectus/sample?flag=AE&rep_id=961

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Follow Us on Linkedin: https://www.linkedin.com/company/factmr/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Non-infectious Diarrhea Treatment Market to Showcase Vigorous Demand during the Period until 2028|| Top industry players- Abbott Laboratories, Aidarex Pharmaceuticals LLC, Atlantic Biologicals Corps, Major Pharmaceuticals, Proficient Rx LP and more here

News-ID: 1299679 • Views:

More Releases from Fact.MR

Agricultural Film Market is forecasted to reach US$ 21 billion with 5.9% CAGR by the end of 2034
Agricultural Film Market is forecasted to reach US$ 21 billion with 5.9% CAGR by …
Fact.MR, a market research and competitive intelligence service, states that historically, the use of Agricultural Films grew at a 3.5% CAGR from 2016 to 2020, with the United States, China, India, and Japan holding a sizable portion of the global market. by 2021, the greenhouse film industry is expected to have grown to a valuation of over US$ 10 billion, largely due to price increases in agricultural films. For More Insights
Medical Equipment Rental Market is projected to expand at a CAGR of 5.5% to reach US$ 98 billion by 2033
04-25-2024 | Health & Medicine
Fact.MR
Medical Equipment Rental Market is projected to expand at a CAGR of 5.5% to reac …
The latest industry analysis from Fact.MR, a company that offers competitive intelligence and market research, projects that the global Medical Equipment Rental Market will grow at a 5.5% CAGR and reach US$ 98 billion in size by the end of 2033. The industry that deals with the short-term rental or lease of medical equipment to healthcare facilities, organizations, and individuals is known as the "medical equipment rental market." The goal of
Craft Beer Market is forecasted to reach a value of US$ 174.68 Billion by 2032
04-24-2024 | Food & Beverage
Fact.MR
Craft Beer Market is forecasted to reach a value of US$ 174.68 Billion by 2032
The worldwide craft beer market was expected to be worth $76.3 billion in 2020 and $81.64 billion in 2021. The market will grow at a steady CAGR of 6.9% between 2022 and 2032. By the end of 2032, this market is predicted to have a global valuation of US$174.68 billion. The surge in demand for more beer styles coupled with increase in per capita income among the target customers has triggered
Window Blinds Market Forecasted to Achieve US$ 4.69 Billion by 2034
Window Blinds Market Forecasted to Achieve US$ 4.69 Billion by 2034
The global window blinds market is expected to reach $2.99 billion in 2024, growing at a 5.8% CAGR to $4.69 billion by the end of 2034. Window blinds are adjustable window coverings made of slats or vanes, allowing for versatile control over light and privacy. They come in various materials, including wood, metal, or plastic, and can be easily adjusted to regulate sunlight and maintain privacy. Unlike heavy curtains, blinds are

All 5 Releases


More Releases for Diarrhea

Carcinoid Syndrome Diarrhea Treatment Market - Increasing prevalence of rare car …
Carcinoid Syndrome Diarrhea Treatment Market report is a exploration database spread across colorful runners with multiple tables and numbers in it. The exploration covers a precious source of perceptive information for business strategists. Carcinoid Syndrome Diarrhea Treatment Industry provides the overview with growth analysis and literal & futuristic cost, profit, demand and force data (as applicable). The exploration judges give an elegant description of the value chain and its distributor
Carcinoid Syndrome Diarrhea Treatment Market
Increasing prevalence of rare carcinoid syndrome diarrhea to boost market growth According to the National Organization for Rare Disorders (NORD), 2017, each year, only 27 individuals per million population are estimated to be diagnosed with carcinoid tumors in the U.S., amongst whom, only 10% individuals develop carcinoid syndrome. Moreover, it affects both males and females in equal number. Increasing prevalence of the disease is in turn, increasing demand for carcinoid syndrome
Carcinoid Syndrome Diarrhea Treatment Market
Carcinoid syndrome is caused by secretion of certain harmful chemicals by carcinoid tumors. Carcinoid syndrome may occur due to infection or other related diseases, and medical or surgical treatments such as anesthesia, chemotherapy, embolization, and tumor debulking. The key symptoms of the syndrome include flushing of the skin and diarrhea, rapid heartbeat, and bronchoconstriction. If remained undiagnosed, it could lead to several complications such as weight loss, electrolyte imbalance, dehydrations,
Diarrhea Therapeutic and Disease Pipeline Review H1
Summary Diarrhea is a contagious gastrointestinal infection occurring mostly due to unhygienic conditions. Diarrhea may be related to a viral or bacterial infection and is sometimes the result of food poisoning. Symptoms include nausea, abdominal pain, cramping, bloating, dehydration, fever, bloody stools, frequent urge to evacuate the bowels and incontinence. Treatment includes medication and healthy lifestyle. GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2811458-diarrhea-pipeline-review-h1-2018 Report Highlights Pharmaceutical and Healthcare latest pipeline guide Diarrhea - Pipeline Review,
Porcine Epidemic Diarrhea Vaccines Sales Market Report : 2017
Reports And Markets Publish a New Market Research Report On –"Porcine Epidemic Diarrhea Vaccines Sales Market Report 2017" Access Full Report With Table Of Contents @ https://www.reportsandmarkets.com/reports/global-porcine-epidemic-diarrhea-vaccines-sales-market-report-2017-1541210 In this report, the global Porcine Epidemic Diarrhea Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global
Diarrhea - Pipeline Insight, Market Research Report 2017
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Diarrhea - Pipeline Insight, 2017”. This report provides comprehensive insights about pipeline drugs across this Diarrhea. The key objective of the report is to establish the understanding for all the pipeline drugs that are undergoing research across Diarrhea. Request For Sample Report@ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1214087 This report provides information on the therapeutic development for Diarrhea, dealing with all